Clene Inc. (CLNN) Stock Analysis

Sector: CONSUMER DEFENSIVE - PACKAGED FOODS

Exchange: NASDAQ

Key Metrics

• Price: $5.36
• Market Cap: $58.42M
• EPS: $-3.44
• 52-Week High: $13.50
• 52-Week Low: $2.28

Market Sentiment

Clene Inc. currently has a Bullish sentiment score of 0.65.

About Clene Inc.

Clene Inc. is an innovative clinical-stage pharmaceutical firm headquartered in Salt Lake City, Utah, specializing in the development of clean-surface nanotechnology (CSN) therapies intended to address neurodegenerative diseases and other critical health conditions. With a strong emphasis on rigorous clinical trials, Clene is focused on achieving regulatory approvals for its advanced product pipeline, which positions the company as a potential leader in transforming treatment options within t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Clene Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CLNN pay dividends?

Clene Inc. (CLNN) does not currently pay a regular dividend.

What is CLNN's market cap?

Clene Inc. (CLNN) has a market capitalization of $58.42M with a current stock price of $5.36.